Extensive & Unique
Tumour Profiling Assays
Coverage from 50 to over 520 genes
Screens for genomics alterations and signatures

Accurate & Sensitive
High accuracy at ≥5% limit of detection
Requiring betwen 10-20% tumour content

Personalized Actionable Reporting
Report as per latest AMP & CAP guidelines
Recommendations based on clinical matching with biomarkers & clinical trials

ESSENTIAL

50 actionable genes for targeted therapy selection

EXTENDED

108 gene hybrid capture panel. Optimized to deliver superior performance

COMPREHENSIVE

Comprehensive therapeutic information for treatment decision and planning